Abingdon Health Plc (LON:ABDX – Get Free Report) shares rose 1.3% during trading on Friday . The stock traded as high as GBX 8 ($0.10) and last traded at GBX 7.60 ($0.10). Approximately 578,419 shares traded hands during mid-day trading, an increase of 160% from the average daily volume of 222,213 shares. The stock had previously closed at GBX 7.50 ($0.09).
Abingdon Health Stock Performance
The business’s fifty day moving average is GBX 8.72 and its 200-day moving average is GBX 9.82. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company has a market cap of £14.40 million, a PE ratio of -899.00 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Articles
- Five stocks we like better than Abingdon Health
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Stock Sentiment Analysis: How it Works
- Top-Performing Non-Leveraged ETFs This Year
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
